XORTX Therapeutics (XRTX) Change in Receivables (2021 - 2026)
XORTX Therapeutics (XRTX) posted Change in Receivables of $15539.0 for Q1 2026, up 126.75% on a QoQ basis from -$58080.0 in Q4 2025, and up 3936.1% year-over-year from $385.0 in Q1 2025.
XORTX Therapeutics (XRTX) Change in Receivables (2021 - 2026) Analysis & Trends
XORTX Therapeutics' Change in Receivables history runs 6 years deep, the most recent figure standing at $15539.0 for Q1 2026.
- Quarterly Change in Receivables rose 3936.1% year-over-year to $15539.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$47381.0 (down 447.6% YoY) and the FY2025 annual result came in at -$62535.0, down 245.18% from the prior year.
- Change in Receivables was $15539.0 for Q1 2026 at XORTX Therapeutics, up from -$58080.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $124837.0 in Q3 2022 and bottomed at -$82291.0 in Q1 2022.
- A 5-year average of -$1856.2 and a median of $6007.0 in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2025 — Change in Receivables tumbled 1183.25% — and 2026, when it surged 3936.1%.
- XORTX Therapeutics' Change in Receivables stood at -$17816.4 in 2022, then surged by 142.26% to $7530.0 in 2023, then tumbled by 160.11% to -$4526.0 in 2024, then tumbled by 1183.25% to -$58080.0 in 2025, then soared by 126.75% to $15539.0 in 2026.
- Business Quant data shows XRTX's Change in Receivables at $15539.0 in Q1 2026, -$58080.0 in Q4 2025, and -$11232.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - | 15,539.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,539.00 |
| Mar 31, 2026 | 15,539.00 |
| Dec 31, 2025 | -58,080.00 |
| Dec 31, 2025 | -58,080.00 |
| Sep 30, 2025 | -11,232.00 |
| Sep 30, 2025 | -11,232.00 |
| Jun 30, 2025 | 6,392.00 |
| Jun 30, 2025 | 6,392.00 |
| Mar 31, 2025 | 385.00 |
| Mar 31, 2025 | 385.00 |
| Dec 31, 2024 | -4,526.00 |
| Dec 31, 2024 | -4,526.00 |
| Sep 30, 2024 | 9,696.00 |
| Sep 30, 2024 | 9,696.00 |
| Jun 30, 2024 | 8,076.00 |
| Jun 30, 2024 | 8,076.00 |
| Mar 31, 2024 | 29,828.00 |
| Mar 31, 2024 | 29,828.00 |
| Dec 31, 2023 | 7,530.00 |
| Dec 31, 2023 | 7,530.00 |